|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the New York Hospital-Cornell Medical Center, New York
In order to define the evolution of airway invasion by esophageal cancer, we reviewed 53 patients presenting with (group A) or without (group B) tracheoesophageal fistulae. Patients in group A were treated by esophageal bypass (4), esophageal diversion (4), expectant therapy (4), or esophageal prosthesis (1). The median survival was 4 months. Group B patients were treated by esophageal resection (18), esophageal bypass (4), or radiation therapy (13), depending on the extent of local disease. Bronchoscopy was a valuable tool for predicting resectability. Surgical resection, when possible, yielded better palliation. There were 4 long-term survivors in group B.
Submitted on October 28, 1993
This article has been cited by other articles:
![]() |
H. Dutau, B. Toutblanc, C. Lamb, and L. Seijo Use of the Dumon Y-stent in the Management of Malignant Disease Involving the Carina: A Retrospective Review of 86 Patients Chest, September 1, 2004; 126(3): 951 - 958. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Riedel, H. J. Stein, L. Mounyam, R. Lembeck, and J. R. Siewert Extensive Sampling Improves Preoperative Bronchoscopic Assessment of Airway Invasion by Supracarinal Esophageal Cancer : A Prospective Study in 166 Patients Chest, June 1, 2001; 119(6): 1652 - 1660. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Alexander, G. D. Trachiotis, T. O. Lipman, and R. G. Wadleigh Evolving management and outcome of esophageal cancer with airway involvement Ann. Thorac. Surg., May 1, 2001; 71(5): 1640 - 1644. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |